IMMUNE DESIGN CORP. Insider Trading for July 2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IMMUNE DESIGN CORP..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in IMMUNE DESIGN CORP. for July 2014.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 305,810 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | X | 0.00 | 305,810 | 0 | 305,810 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | X | 8.18 | 305,810 | 2,499,997 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 611,620 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 531,840 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 733,941 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Buy | P | 12.00 | 233,333 | 2,799,996 | 2,208,210 | 2 M to 2.2 M (+11.82 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 12.00 | 208,334 | 2,500,008 | 1,974,877 | 2.2 M to 2 M (-9.54 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 305,810 | 0 | 2,183,211 | 1.9 M to 2.2 M (+16.29 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 611,620 | 0 | 1,877,401 | 1.3 M to 1.9 M (+48.32 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 531,840 | 0 | 1,265,781 | 733.9 K to 1.3 M (+72.46 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 733,941 | 0 | 733,941 | 0 to 733.9 K |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 428,134 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | X | 0.00 | 428,134 | 0 | 428,134 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | X | 8.18 | 428,134 | 3,499,995 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 856,269 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 744,580 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 733,943 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Buy | P | 12.00 | 399,016 | 4,788,192 | 3,161,942 | 2.8 M to 3.2 M (+14.44 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Buy | C | 0.00 | 428,134 | 0 | 2,762,926 | 2.3 M to 2.8 M (+18.34 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Buy | C | 0.00 | 856,269 | 0 | 2,334,792 | 1.5 M to 2.3 M (+57.91 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Buy | C | 0.00 | 744,580 | 0 | 1,478,523 | 733.9 K to 1.5 M (+101.45 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Svennilson Peter | Director | Buy | C | 0.00 | 733,943 | 0 | 733,943 | 0 to 733.9 K |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 305,810 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Option Exercise | X | 0.00 | 305,810 | 0 | 305,810 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Option Exercise | X | 8.18 | 305,810 | 2,499,997 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 611,620 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,595,530 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | P | 12.00 | 391,131 | 4,693,572 | 2,695,757 | 2.3 M to 2.7 M (+16.97 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Sell | S | 12.00 | 208,334 | 2,500,008 | 2,304,626 | 2.5 M to 2.3 M (-8.29 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | C | 0.00 | 305,810 | 0 | 2,512,960 | 2.2 M to 2.5 M (+13.86 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | C | 0.00 | 611,620 | 0 | 2,207,150 | 1.6 M to 2.2 M (+38.33 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ProQuest Investments IV, L.P. | 10% Owner | Buy | C | 0.00 | 1,595,530 | 0 | 1,595,530 | 0 to 1.6 M |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 305,810 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | X | 0.00 | 305,810 | 0 | 305,810 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | X | 8.18 | 305,810 | 2,499,997 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 611,620 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 531,843 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Option Exercise | C | 0.00 | 733,943 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Buy | P | 12.00 | 299,559 | 3,594,708 | 2,482,775 | 2.2 M to 2.5 M (+13.72 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 305,810 | 0 | 2,183,216 | 1.9 M to 2.2 M (+16.29 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 611,620 | 0 | 1,877,406 | 1.3 M to 1.9 M (+48.32 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 531,843 | 0 | 1,265,786 | 733.9 K to 1.3 M (+72.46 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | PENHOET EDWARD | Director | Buy | C | 0.00 | 733,943 | 0 | 733,943 | 0 to 733.9 K |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 428,134 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Option Exercise | X | 0.00 | 428,134 | 0 | 428,134 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Option Exercise | X | 8.18 | 428,134 | 3,499,995 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 856,269 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 744,580 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 733,943 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Buy | P | 12.00 | 399,016 | 4,788,192 | 3,161,942 | 2.8 M to 3.2 M (+14.44 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Buy | C | 0.00 | 428,134 | 0 | 2,762,926 | 2.3 M to 2.8 M (+18.34 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Buy | C | 0.00 | 856,269 | 0 | 2,334,792 | 1.5 M to 2.3 M (+57.91 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Buy | C | 0.00 | 744,580 | 0 | 1,478,523 | 733.9 K to 1.5 M (+101.45 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | COLUMN GROUP L P | 10% Owner | Buy | C | 0.00 | 733,943 | 0 | 733,943 | 0 to 733.9 K |
Jul 31 2014 | IMDZ | Immune Design Corp ... | BERGER FRANKLIN M | Director | Buy | P | 12.00 | 50,000 | 600,000 | 50,000 | 0 to 50 K |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 305,810 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | X | 0.00 | 305,810 | 0 | 305,810 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | X | 8.18 | 305,810 | 2,499,997 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 611,620 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 531,840 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Option Exercise | C | 0.00 | 733,941 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Buy | P | 12.00 | 233,333 | 2,799,996 | 2,208,210 | 2 M to 2.2 M (+11.82 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Sell | S | 12.00 | 208,334 | 2,500,008 | 1,974,877 | 2.2 M to 2 M (-9.54 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 305,810 | 0 | 2,183,211 | 1.9 M to 2.2 M (+16.29 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 611,620 | 0 | 1,877,401 | 1.3 M to 1.9 M (+48.32 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 531,840 | 0 | 1,265,781 | 733.9 K to 1.3 M (+72.46 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | ATWOOD BRIAN G | Director | Buy | C | 0.00 | 733,941 | 0 | 733,941 | 0 to 733.9 K |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 305,810 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | X | 0.00 | 305,810 | 0 | 305,810 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | X | 8.18 | 305,810 | 2,499,997 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 611,620 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 531,843 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Option Exercise | C | 0.00 | 733,943 | 0 | 0 | |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Buy | P | 12.00 | 299,559 | 3,594,708 | 2,482,775 | 2.2 M to 2.5 M (+13.72 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 305,810 | 0 | 2,183,216 | 1.9 M to 2.2 M (+16.29 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 611,620 | 0 | 1,877,406 | 1.3 M to 1.9 M (+48.32 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 531,843 | 0 | 1,265,786 | 733.9 K to 1.3 M (+72.46 %) |
Jul 31 2014 | IMDZ | Immune Design Corp ... | Alta Partners VIII, L.P. | 10% Owner | Buy | C | 0.00 | 733,943 | 0 | 733,943 | 0 to 733.9 K |